Clinical Trials Directory

Trials / Completed

CompletedNCT01534689

Study of the Use of Low Level Laser Light Therapy to Treat Toenail Fungus

An Evaluation of the Effect of the Erchonia FX-405™ on Treating Toenail Onychomycosis Clinical Study

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
105 (actual)
Sponsor
Erchonia Corporation · Industry
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

The purpose of this study is to determine whether low level laser light is effective in the treatment of toenail fungus.

Detailed description

An infection of toenail fungus, or onychomycosis, occurs when fungi infect one or more nails. As the nail fungus spreads deeper into the nail, it may cause nail discoloration, thickening and the development of crumbling edges, all of which can lead to an unsightly and potentially painful problem. Onychomycosis is difficult to treat, and infections recur easily. Toenail fungus affects approximately 23 million people in the US - about 10% of all adults. Currently available treatments for toenail fungus are lacking. Even the most effective oral medications are successful only about half of the time. Topical medications are successful less than 10% of the time. Recently, research has found laser therapy to show promise as a novel alternative treatment for toenail onychomycosis. Unlike medication-driven treatments for toenail fungus which can have many side effects including serious ones such as liver toxicity, laser therapy presents minimal risk of side effects. Laser therapy is applied to toenail onychomycosis by shining a laser light through the toenail. The laser light vaporizes the fungus while leaving the skin and surrounding tissue unharmed.

Conditions

Interventions

TypeNameDescription
DEVICEErchonia FX-405™ LaserThe Erchonia FX-405™ dual diode laser light is directed at the great toenail at a distance of approximately 6 inches above the toenail. The dual wavelengths of 405 nm and 635 nm are activated simultaneously for 10 minutes of total treatment administration time.

Timeline

Start date
2011-04-01
Primary completion
2012-04-01
Completion
2012-04-01
First posted
2012-02-17
Last updated
2015-12-11
Results posted
2015-12-11

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT01534689. Inclusion in this directory is not an endorsement.